Marty Morantz on Questions Passed as Orders for Returns

With regard to the government's $173 million agreement with Medicago to develop a COVID-19 vaccine and the decision of the World Health Organization (WHO) not to accept the vaccine for emergency use: (a) was the government aware that Medicago being partially owned by a tobacco company would cause a problem related to WHO authorization prior to the agreement being signed, and, if so, why did the government still proceed with the agreement; (b) on what date did the government first become aware that Philip Morris' ownership stake in Medicago would become an issue with the WHO; (c) has any minister made a formal request or representation to the WHO related to the Covifenz vaccine issue, and, if so, what are the details, including, for each instance, the (i) date, (ii) name of the minister, (iii) summary of how requests or representations were made, (iv) title of the WHO official receiving requests or representations; (d) what is the breakdown by country of how the 20 million Covifenz vaccine doses under contract by the government are to be distributed; (e) how many of the doses in (d) have actually been distributed to date; (f) how many Covifenz doses had the government originally planned to be part of Canada's international COVAX commitment; and (g) has the government replaced the committed doses in (f) with another COVID-19 vaccine, and, if so, which one?